… Cancer Research UK to take cutting edge innovations in research and treatment … mouth cancer for patients and much easier for doctors … the Human Papillomavirus Virus vaccine, which is expected … abiraterone - a drug that gives men with advanced prostate cancer …

A panelist discusses how genomic classifiers play a crucial role in determining whether treatment intensification with agents like abiraterone is beneficial for patients with high-risk localized prostate cancer.

A panelist discusses how a 62-year-old man with high-risk localized prostate cancer was treated with intensified therapy, including abiraterone plus radiation, but experienced tolerability issues with the traditional fasting formulation.

… treatment strategies for patients with metastatic castration-sensitive prostate cancer … benefit from abiraterone-based treatments, although individual … drug interactions. Careful evaluation of concurrent medications … Triple Switch trial represents a significant …

… (PARP) inhibitors Akeega (niraparib and abiraterone acetate) tablets Lynparza (olaparib) tablets … . Xcopri (cenobamate tablets) Drug-induced liver injury FDA is evaluating the need …

… from the fear of cancer. Cancer Research UK’s Race … the Human Papillomavirus Virus vaccine, which is expected to … Cancer Research UK played a leading role in the development of abiraterone … - a drug that gives men with advanced prostate cancer …

… trial evaluating niraparib (Zejula) and abiraterone acetate (Zytiga) plus prednisone for the treatment … of metastatic castration-sensitive prostate cancer … the medical community … more drugs also …

… androgen receptor–dependent proliferation of prostate cancer cells in vitro. The … in patients with prostate cancer unresponsive to standard abiraterone and prednisone therapy … the urinary tract in primary prostate cancer is warranted.” Future therapeutic …

… prostate cancer (mCSPC). Here, Biren Saraiya, MD, medical oncologist at Rutgers Cancer … the MAGNITUDE trial. Eligible … . However, treatment discontinuations due … abiraterone acetate plus prednisone (AAP) for metastatic castration-sensitive prostate cancer …

… (ARPIs), chemotherapy, radiopharmaceuticals, and … trial (NCT02125357) showed that treatment sequence matters: abiraterone … prostate cancer cells.22-24 Antibody-drug … abiraterone acetate plus prednisone in metastatic castration-resistant prostate cancer …